lovastatin has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchwald, ZS; Burnham, AJ; Kansal, V; Kinney, BLC; Lesinski, GB; Paulos, C; Saba, NF; Schmitt, NC | 1 |
1 other study(ies) available for lovastatin and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.
Topics: Animals; Head and Neck Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Checkpoint Inhibitors; Lovastatin; Mice; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |